These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 30131321)
1. Oral vancomycin induces clinical and mucosal remission of colitis in children with primary sclerosing cholangitis-ulcerative colitis. Tan LZ; Reilly CR; Steward-Harrison LC; Balouch F; Muir R; Lewindon PJ Gut; 2019 Aug; 68(8):1533-1535. PubMed ID: 30131321 [No Abstract] [Full Text] [Related]
2. Oral Vancomycin Induced and Maintained Clinical and Endoscopic Remission in Ulcerative Colitis and Primary Sclerosing Cholangitis Post-liver Transplantation. Almomen HS; Al-Bawardy B Inflamm Bowel Dis; 2023 May; 29(5):837-838. PubMed ID: 36888548 [TBL] [Abstract][Full Text] [Related]
3. The role of oral vancomycin in inducing remission for biologic-experienced ulcerative colitis with concomitant primary sclerosing cholangitis and liver transplantation. Rahman AU; Inayat F; Ali S; Zahid E; Charles R Clin J Gastroenterol; 2021 Feb; 14(1):159-164. PubMed ID: 33130984 [TBL] [Abstract][Full Text] [Related]
4. Oral vancomycin induces sustained deep remission in adult patients with ulcerative colitis and primary sclerosing cholangitis. de Chambrun GP; Nachury M; Funakoshi N; Gerard R; Bismuth M; Valats JC; Panaro F; Navarro F; Desreumaux P; Pariente B; Blanc P Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1247-1252. PubMed ID: 30052539 [TBL] [Abstract][Full Text] [Related]
5. Oral Vancomycin Induces and Maintains Remission of Ulcerative Colitis in the Subset of Patients With Associated Primary Sclerosing Cholangitis. Dao A; Abidian M; Lestrange A; Mattar M; Rangnekar A; Charabaty A Inflamm Bowel Dis; 2019 Jun; 25(7):e90-e91. PubMed ID: 30838381 [No Abstract] [Full Text] [Related]
6. HLA antigens in ulcerative colitis and primary sclerosing cholangitis. Leidenius MH; Koskimies SA; Kellokumpu IH; Höckerstedt KA APMIS; 1995; 103(7-8):519-24. PubMed ID: 7576567 [TBL] [Abstract][Full Text] [Related]
7. Successful response of primary sclerosing cholangitis and associated ulcerative colitis to oral vancomycin may depend on brand and personalized dose: report in an adolescent. Buness CW; Johnson KM; Ali AH; Alrabadi L; Lindor KD; Miloh T; Cox KL Clin J Gastroenterol; 2021 Apr; 14(2):684-689. PubMed ID: 33231850 [TBL] [Abstract][Full Text] [Related]
9. Atrophy and neoplastic transformation of the ileal pouch mucosa in patients with ulcerative colitis and primary sclerosing cholangitis: a case control study. Ståhlberg D; Veress B; Tribukait B; Broomé U Dis Colon Rectum; 2003 Jun; 46(6):770-8. PubMed ID: 12794579 [TBL] [Abstract][Full Text] [Related]
10. Besting the Biologics: Vancomycin Monotherapy for Ulcerative Colitis Management in Patients with Primary Sclerosing Cholangitis. Ahmed T; Kayal M; Hashem D; Ungaro RC Dig Dis Sci; 2023 Apr; 68(4):1118-1120. PubMed ID: 36881200 [No Abstract] [Full Text] [Related]
11. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Tung BY; Emond MJ; Haggitt RC; Bronner MP; Kimmey MB; Kowdley KV; Brentnall TA Ann Intern Med; 2001 Jan; 134(2):89-95. PubMed ID: 11177311 [TBL] [Abstract][Full Text] [Related]
12. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis. Seibold F; Slametschka D; Gregor M; Weber P Gastroenterology; 1994 Aug; 107(2):532-6. PubMed ID: 8039629 [TBL] [Abstract][Full Text] [Related]
13. Does colitis associated with primary sclerosing cholangitis represent an actual subset of ulcerative colitis? Oshitani N; Jinno Y; Sawa Y; Nakamura S; Matsumoto T; Nishiguchi S; Seki S; Higuchi K; Arakawa T Hepatogastroenterology; 2003; 50(54):1830-5. PubMed ID: 14696415 [TBL] [Abstract][Full Text] [Related]
14. Cytokine production from colonic T cells in patients with ulcerative colitis with and without primary sclerosing cholangitis. Broomé U; Hultcrantz R; Lefvert AK; Yi Q Dis Colon Rectum; 1998 Dec; 41(12):1543-9. PubMed ID: 9860336 [TBL] [Abstract][Full Text] [Related]
15. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Soetikno RM; Lin OS; Heidenreich PA; Young HS; Blackstone MO Gastrointest Endosc; 2002 Jul; 56(1):48-54. PubMed ID: 12085034 [TBL] [Abstract][Full Text] [Related]
16. Surgical management of ulcerative colitis in the presence of primary sclerosing cholangitis. Poritz LS; Koltun WA Dis Colon Rectum; 2003 Feb; 46(2):173-8. PubMed ID: 12576890 [TBL] [Abstract][Full Text] [Related]
17. Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study. Lindberg BU; Broomé U; Persson B Dis Colon Rectum; 2001 Jan; 44(1):77-85. PubMed ID: 11805567 [TBL] [Abstract][Full Text] [Related]
18. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Duerr RH; Targan SR; Landers CJ; LaRusso NF; Lindsay KL; Wiesner RH; Shanahan F Gastroenterology; 1991 May; 100(5 Pt 1):1385-91. PubMed ID: 2013383 [TBL] [Abstract][Full Text] [Related]